Work

Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression

Year: 2011

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2010-08-304477

Authors: Claire M. Lucas, Robert J. Harris, Athina Giannoudis, Mhairi Copland, Joseph R. Slupsky, Richard E. Clark

Institutions: University of Liverpool, Gartnavel General Hospital, University of Glasgow

Language: English

Topic: Chronic Myeloid Leukemia Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: University of Liverpool

OpenAlex ID: W2040802938

FWCI: 8.758

Cites: 36

Cited by: 139

Related to: 10